🇺🇸 FDA
Pipeline program

PH-10 (rose bengal disodium 0.001%)

PH-10-PS-21

Phase 2 small_molecule terminated

Quick answer

PH-10 (rose bengal disodium 0.001%) for Plaque Psoriasis is a Phase 2 program (small_molecule) at PROVECTUS BIOPHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PROVECTUS BIOPHARMACEUTICALS, INC.
Indication
Plaque Psoriasis
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials